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Summary
Protein microbicides against HIV can help to prevent infection but they are required in large,
repetitive doses. This makes current fermenter-based production systems prohibitively expensive.
Plants are advantageous as production platforms because they offer a safe, economical and
scalable alternative, and cereals such as rice are particularly attractive because they could allow
pharmaceutical proteins to be produced economically and on a large scale in developing
countries. Pharmaceutical proteins can also be stored as unprocessed seed, circumventing the
need for a cold chain. Here, we report the development of transgenic rice plants expressing the
HIV-neutralizing antibody 2G12 in the endosperm. Surprisingly for an antibody expressed in
plants, the heavy chain was predominantly aglycosylated. Nevertheless, the heavy and light
chains assembled into functional antibodies with more potent HIV-neutralizing activity than
other plant-derived forms of 2G12 bearing typical high-mannose or plant complex-type glycans.
Immunolocalization experiments showed that the assembled antibody accumulated predomi-
nantly in protein storage vacuoles but also induced the formation of novel, spherical storage
compartments surrounded by ribosomes indicating that they originated from the endoplasmic
reticulum. The comparison of wild-type and transgenic plants at the transcriptomic and
proteomic levels indicated that endogenous genes related to starch biosynthesis were down-
regulated in the endosperm of the transgenic plants, whereas genes encoding prolamin and
glutaredoxin-C8 were up-regulated. Our data provide insight into factors that affect the
functional efficacy of neutralizing antibodies in plants and the impact of recombinant proteins on
endogenous gene expression.
Introduction
More than 35 million people are currently living with HIV/AIDS
(UNAIDS, 2013). Most of the infected population lives in sub-
Saharan Africa, where the disease caused more than 1.8 million
deaths in 2012. Although the number of deaths caused by HIV/
AIDS has declined over the last few years due to the deployment
of antiretroviral drugs, the virus continues to spread because
there are no effective vaccines, and prophylaxis still remains
reliant on barrier methods or abstinence, both of which are
characterized by poor compliance. Microbicides containing
antiretroviral drugs and/or HIV-neutralizing antibodies could
potentially be used to prevent the transmission of HIV if sufficient
quantities could be supplied to protect the at-risk population
(Ramessar et al., 2010).
HIV-1 entry into susceptible cells requires the envelope (Env)
protein, a trimer of gp120/gp41 heterodimers with gp120 acting
as the external surface subunit that engages cellular receptors,
and gp41 as the transmembrane subunit that mediates mem-
brane fusion (Poignard et al., 2001). The gp120 protein interacts
with CD4 on the surface of lymphocytes and then with the
coreceptor CCR5 or CXCR4, so antibodies against gp120/gp41
can be used to prevent the uptake of HIV into target cells. A panel
of broadly neutralizing anti-HIV antibodies has been described,
and these differ in terms of the HIV strains and clades that are
neutralized and the potency of neutralization in vitro (reviewed by
McCoy and Weiss, 2013). However, only a few of the antibodies
have been tested in preclinical studies for their ability to prevent
the transmission of HIV, or the related model virus SHIV, in animal
experiments (Ramessar et al., 2010).
HIV-neutralizing antibodies 2G12, 2F5 and 4E10 have been
produced in Chinese hamster ovary (CHO) cells for prophylactic
and therapeutic use (Hofmann-Lehmann et al., 2001; Stiegler
et al., 2002) but although yields of 5–10 g/L can be achieved
in commercial antibody manufacturing processes, the draw-
backs of this platform include the high costs of fermentation
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and downstream processing infrastructure as required for
compliance with good manufacturing practice (GMP), and the
high running costs, which translate into a correspondingly high
cost of goods. CHO cells are therefore economically suitable for
the manufacture of injectable antibodies for specific forms of
cancer (small patient populations, low doses) but not for
microbicide applications where the target population numbers
in the millions and large, repetitive doses of multiple antibodies
are required (Ma et al., 2013). The cost and capacity aspects
make this platform unfeasible to deploy in developing countries
because 100–1000 kg of each antibody would be required
annually and each microbicide would require 2–3 antibodies
targeting different epitopes to prevent the emergence of
‘escapes’ (Ramessar et al., 2010). CHO cells also have low
capacity/scalability, and safety risks arise due to the potential
for contamination with viruses (Chu and Robinson, 2001;
St€oger et al., 2000, 2002, 2005).
Plants could potentially be developed into a platform for the
large-scale production of prophylactic antibodies because they
are inexpensive to cultivate, more scalable than any other
platform and, for these reasons, should be easy to deploy in
developing countries (Fischer et al., 2004; Ma et al., 2003; Paul
et al., 2013; Ramessar et al., 2010). Technoeconomic evaluation
in tobacco, maize and rice has shown that upstream production
costs can be reduced to 5% of the cost of fermentation, mainly
because plants can be grown in greenhouses that do not need
to be GMP ready (Tuse et al., 2014). Although pioneering work
has been carried out using tobacco, cereal seeds are likely to be
the most suitable platform for deployment in such areas
because the infrastructure for large-scale cultivation and har-
vesting is already in place and the dry seeds favour product
stability (Lotter-Stark et al., 2012; Ramessar et al., 2008c).
Cereal seeds also have GRAS status which means that crude
seed extracts containing antibodies could be used to produce
microbicides, removing the need for downstream processing
which accounts for up to 80% of overall production costs in
plants, and this minimal processing concept has already been
demonstrated for other proteins (Ning et al., 2008; Xie et al.,
2008). Rice as a platform for molecular farming provides unique
advantages in terms of protein storage compartments derived
from the endomembrane system in the seeds (Drakakaki et al.,
2006; Khan et al., 2012). Several reports have described the
economic viability of production processes based on maize and
rice, even when downstream processing is included (Evangelista
et al., 1998; Nandi et al., 2005). In sub-Saharan Africa, which
suffers the greatest HIV burden in the world, rice is not grown
as widely as maize, and the latter has already been investigated
as a potential source of HIV-neutralizing antibodies (Rademacher
et al., 2008; Ramessar et al., 2008b). However, pharmaceutical
transgenic crops would be grown in containment rather than in
the field, at least initially, so it makes sense to compare the
productivity of different cereals and the activity of the antibodies
produced therein to find the most promising cultivation system
for antibody production in containment (Kuo et al., 2013;
Ramessar et al., 2008a).
Here, we investigated the accumulation of antibody 2G12 in
rice endosperm focusing on its sequestration into subcellular
storage compartments. We also investigated the glycosylation of
the antibody heavy chain and its impact on the binding behaviour
and HIV-neutralizing properties of the assembled antibody. The
impact of our results on the production of prophylactic, HIV-
neutralizing antibodies in plants is discussed.
Results
Generation of transgenic rice plants expressing the
HIV-neutralizing antibody 2G12
Rice embryos were transformed by particle bombardment with
constructs containing the coding sequences for the 2G12 heavy
and light chains, under the control of the rice glutelin-1 promoter
(Ramessar et al., 2008b) plus a third construct containing the
selectable marker hpt (Christou and Ford, 1995). Embryo-derived
callus was selected on hygromycin-supplemented medium, and
20 independent transformants were regenerated and transferred
to the greenhouse. Leaves and seeds from these plants were
analysed by PCR to confirm the presence of the transgene, by dot
blot to confirm transgene expression and by immunoglobulin-
specific sandwich ELISA to confirm the presence of correctly
assembled 2G12. Six independent lines expressing 2G12 at the
highest levels were self-pollinated to produce T1 and T2 seeds for
more detailed analysis.
Confirmation of antibody assembly in T1 transgenic
endosperm
The presence of correctly assembled 2G12 in T1 rice endosperm
was confirmed using the immunoglobulin-specific sandwich
ELISA described above. The antibody content of the endosperm
was determined by calculating the concentrations from titration
curves based on positive controls spiked with known concen-
trations of the same antibody produced in maize, which is
immunologically identical to the commercial CHO standard
(Figure 1). We used nontransformed rice endosperm as a
negative control to rule out cross-reaction between the immu-
noglobulin-specific detection antibody and endogenous plant
proteins. Among the six independent lines expressing both
antibody chains, we selected the two lines (4 and 14) producing
the highest levels of assembled 2G12 for more detailed
investigation. The yield of 2G12 in the best performing line
(14) was 37.168 lg/g in the T1 generation, but this increased to
46.4 lg/g in the T3 generation after two rounds of self-
pollination.
Accumulation of 2G12 in rice endosperm induces the
formation of novel protein bodies
The localization of 2G12 in the endosperm of lines 4 and 14 was
investigated by fluorescence microscopy and transmission elec-
tron microscopy (TEM). Colocalization with glutelin indicated that
most of the antibody accumulates in the protein storage vacuoles
(glutelin bodies, PB-II), but additional labelling was detected
outside these organelles (Figure 2a–c). Consistent with this result,
TEM showed that most of the antibody had accumulated in
glutelin bodies and only a small amount in the ER-derived
prolamin bodies (also known as type-I protein bodies, PB-I). In the
transgenic endosperm, we also observed novel protein bodies
that were studded with ribosomes although these bodies did not
show significant labelling (Figure 3a–b). There was no evidence of
2G12 labelling in the untransformed control plants.
The 2G12 heavy chain in rice endosperm is
predominantly aglycosylated
The 2G12 antibody was purified from rice endosperm extracts by
protein A affinity chromatography. Neither the flow through nor
the wash fractions contained measurable amounts of the 2G12
heavy and light chains, indicating that the antibody assembled
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correctly in planta and was retained efficiently on the resin. The
final concentration of pure antibody from the T1 generation was
34 lg/g dry seed weight, representing a recovery of 97%, but
after protocol optimization and two rounds of self-pollination to
produce T3 homozygous seeds, the antibody concentration
increased to 42 lg/g dry seed weight, representing a recovery
of 96%. The presence of the heavy and light chains was
confirmed by reducing SDS-PAGE (50- and 25-kDa bands). No
degradation products were present, suggesting the antibody
remained stable in the seeds (Figure 4).
The purified antibody heavy chain was digested with trypsin
and analysed by MALDI-TOF mass spectrometry. Remarkably, we
found that 50% of the EEQYNSTYR peptide, which contains the
specific NSx glycan acceptor sequence responsible for heavy chain
glycosylation, was completely aglycosylated. Among the remain-
der, 19% and 14% contained vacuolar-type N-glycans (MUXF
and MMXF, respectively), 13% carried a single N-acetylglucos-
amine (GlcNAc) attached to the asparagine residue, suggesting
the presence of ENGase activity in the early part of the secretory
pathway, and the remaining 4% carried high-mannose glycans of
the Man7 configuration (Figure 5).
The underglycosylated OS2G12 shows normal binding
activity but enhanced HIV-neutralization activity relative
to NT2G12
Because 50% of the 2G12 heavy chain peptide was aglycosylated
in rice, statistically (assuming random association between
chains), it is likely that 25% of the assembled antibody
(OS2G12) is fully aglycosylated, 50% is hemiglycosylated and
25% is fully glycosylated, with only a minor fraction containing
complex-type glycans on both chains. The ability of the antibody
to bind gp120 was tested in vitro using an antigen-specific ELISA
with both the purified antibody and the crude extracts of each
rice line. The capture reagent was gp120-IIIB and the bound
2G12 was detected using a mixture of anti-human gamma and
anti-human kappa antibodies, which bind the heavy and light
chains, respectively. The transgenic endosperm extracts showed
higher gp120-binding activity than wild-type endosperm extracts
as expected, which confirmed that the assembled 2G12 produced
in the transgenic endosperm was functional. The binding activity
of the crude extracts was consistent with the concentration of
antibody relative to the purified OS2G12, which demonstrated
near identical binding activity to the 2G12 produced in maize
(ZM2G12) which was used as a positive control (Figure 6).
The HIV-neutralizing activity of the purified OS2G12 was
compared to the same antibodies produced in and purified from
CHO cells (CHO2G12) and tobacco (NT2G12) and to an unrelated
pure antibody recognizing a different antigen (antirabies antibody
(a)
(b)
(c)
Figure 2 Localization of 2G12 and the seed storage protein glutelin in
rice endosperm. Immunofluorescence microscopy confirmed that 2G12
(line 4) accumulated in the protein storage vacuoles (glutelin bodies, PB-II)
and to a lesser extent in prolamin bodies (PB-I). (a) Red fluorescence shows
the localization of 2G12; (b) Green fluorescence shows the localization of
glutelin; (c) Yellow fluorescence shows the colocalization of 2G12 and
glutelin. Antibody 2G12 was detected with a polyclonal rabbit anti-HC or
anti-LC antiserum diluted 1 : 100 and a secondary AlexaFluor 594-
conjugated goat anti-rabbit IgG (red fluorophore). An antiglutelin
antibody (green fluorophore) was used to detect endogenous glutelin.
Figure 1 The expression of 2G12 in mature rice endosperm. An
immunoglobulin-specific sandwich ELISA procedure was used to screen
endosperm extracts from independent transgenic lines for 2G12. The
plates were coated with an anti-human j-chain antibody, and captured
2G12 was detected with an anti-human IgG antibody labelled with
horseradish peroxidase. Four serial dilutions were loaded per sample (neat,
1/2, 1/4 and 1/8). WT = wild-type extracts; C = negative control (PBS);
C+ = 2G12 purified from maize (500 ng/mL) as positive control.
OD = optical density at 450 nm.
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E559) all at starting concentrations of 100 lg/mL. The potency of
HIV neutralization was determined using a syncytium inhibition
assay with HIV-1 BaL. The 50% inhibitory concentration (IC50)
was 1.197 lg/mL for OS2G12, 0.083 lg/mL for CHO2G12 and
7.889 lg/mL for NT2G12, demonstrating that CHO2G12 was 14
times more potent than OS2G12, but OS2G12 was approximately
seven times more potent than NT2G12, which was a significant
difference at P < 0.05 (Figure 7).
Proteomic analysis and transcript profiling reveal genes
modulated by 2G12 expression in rice endosperm
Comparative proteomic analysis was carried out using transgenic
lines 7, 10, 12 and 14 and a wild-type control, revealing two
major up-regulated proteins and two major down-regulated
proteins in the transgenic plants (Table 1). One of the up-
regulated proteins was the storage protein prolamin and the
other was the enzyme glutaredoxin-C8. Both the down-regulated
proteins were related to starch synthesis and storage. We also
measured the abundance of the corresponding transcripts in the
same four transgenic lines by quantitative real-time RT-PCR to
correlate the mRNA and protein levels of the modulated genes.
Accordingly, we found that the transcript levels of endogenous
starch-branching enzyme (GLGB _ORYSJ) and ADP-glucose pyro-
phosphorylase (GLGS _ORYSJ) were down-regulated in all the
transgenic lines compared to wild-type plants (Figure S1 a–b) and
that the expression levels of endogenous glutaredoxin-C8
(GRXC8 _ORYSJ) and prolamin PPROL 14E (PRO7_ORYSJ) were
up-regulated in all the transgenic lines compared to wild-type
plants (Figure S1 c–d).
(a)
(b)
Figure 3 Localization of 2G12 in the rice endosperm by electron
microscopy. Ultrathin sections of immature rice seeds (line 14) revealed (a)
the accumulation of 2G12 mostly in PB-II structures and more sparsely in
PB-I structures, (b) the presence of novel bodies surrounded by ribosomes
(white arrows). Bar = 500 nm. Antibody 2G12 was detected with a
polyclonal goat anti-HC or anti-LC antibody (diluted 1 : 100 in PBS) and a
secondary donkey anti-goat IgG coupled to 15-nm colloidal gold diluted
1 : 30 in PBS.
Figure 4 SDS-PAGE analysis of 2G12 purified from rice endosperm.
Fractions eluting from the protein A column were separated by SDS-PAGE
(12% polyacrylamide) under reducing conditions, and the gels were
stained with Coomassie Brilliant Blue. The heavy (H) and light (L) chains
were identified, and no degradation products were observed.
M = molecular weight markers. Lanes 1 and 2 were loaded with 2 and
5 lg of 2G12 (line 14), respectively.
Figure 5 Glycosylation profile of 2G12 purified from rice endosperm.
Deconvoluted mass spectrum (m/z = 1100–3100) of the tryptic
glycopeptide derived from the 2G12 heavy chain (band H shown in Fig. 4).
MMXF = paucimannosidic structures, Man7 = mannose 7.
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Discussion
Protein microbicides against HIV can help to prevent the
transmission of the virus, as demonstrated in a number of
preclinical and clinical studies (De Clercq, 2007; Nutan and
Gupta, 2011) concerning anionic polymers and polyanions (El-
Sadr et al., 2006; Joshi et al., 2006; McCormack et al., 2005;
Patton et al., 2006), CCR5 inhibitors (Kawamura et al., 2003)
and fusion inhibitors (Ramessar et al., 2010). However, the
production and distribution of therapeutic proteins using tradi-
tional CHO-based fermenters are challenging and expensive in
key HIV-endemic areas because there is only a limited amount of
GMP-ready production infrastructure and the cold chain is often
unreliable (Fischer et al., 2012; Ma et al., 2013; Rybicki, 2014).
Therapeutic proteins have been expressed in plants, including a
large number of vaccine candidates and recombinant antibodies,
so the principle of pharmaceutical molecular farming is well
established (Ramessar et al., 2008a; Twyman et al., 2005). Plants
have many technoeconomic advantages over fermenter-based
systems because upstream production does not require expensive
GMP facilities and can be achieved using greenhouses which cost
less to build and operate and are much more scalable, thereby
providing an opportunity for the production of antibodies as
‘commodities’ despite the lower yields achieved in plants (Hood
et al., 2002; Ma et al., 2003; Paul et al., 2013; Ramessar et al.,
2008a). Although many of the economic advantages of plants are
offset by the high costs of downstream processing, cereal seeds
such as rice and maize are suitable for minimal processing
strategies because they have GRAS status, so pharmaceutical
products can be orally administered as whole seeds, flakes or
flour (Ning et al., 2008; Xie et al., 2008) and also made into
pastes for topical applications (Paul et al., 2013; Ramessar et al.,
2008a).
Several detailed economic studies have been carried out for
recombinant proteins produced in rice seeds. For example, He
et al. (2011) have shown that rice seeds are cost-effective for the
production of recombinant human serum albumin, which like
microbicide antibodies is also required on a large scale. Zhang
et al. (2012) developed a cost-effective process for the produc-
tion and downstream processing of recombinant human a1-
antitrypsin. Furthermore, An et al. (2013) showed that rice
endosperm cells can express atypical proteins such as hydropho-
bic proteins or those with a low molecular mass. Nandi et al.
(2005) described the production and processing of recombinant
human lactoferrin in rice, revealing that the cost of goods could
be reduced to as little as $US 5.90 per gram with a productivity of
600 kg per year. The authors of this study represent the US
Figure 6 Antigen-binding activity of crude extracts from rice endosperm
and purified 2G12. ELISA was used to determine the binding activity of
purified 2G12 and serially diluted crude extracts of rice endosperm
expressing the same protein. Plates were coated with the HIV gp120
protein, and bound 2G12 was detected with a mixture of anti-human
j-chain and anti-human IgG antibodies labelled with horseradish
peroxidase. Values represent the average of two experiments, and bars
indicate standard deviations. The binding kinetics showed a concentration-
dependent relationship. All the crude extracts showed higher binding
kinetics compared to wild-type extracts (negative control) and purified
2G12 (positive control). WT = wild-type extracts; C = negative control
(PBS); C+UG = underglycosylated 2G12 purified from rice (500 ng/mL) as a
positive control; C+G = glycosylated 2G12 purified from maize (500 ng/
mL) as a positive control; OD = optical density at 450 nm.
Figure 7 In vitro virus neutralization efficacy of 2G12 from different
sources. HIV neutralization was measured using a syncytium inhibition
assay (Montefiori, 2005; Wei et al., 2003) with HIV-1 strain BaL,
representing clade B (HIV-1 is divided into four groups (M, N, O and P),
and within group M, there are at least nine distinct subtypes (or clades)
named A, B, C, D, F, G, H, J and K). An unrelated plant-derived antirabies
antibody E559 was used as a negative control.
Table 1 The two most strongly up-regulated and down-regulated
proteins in each transgenic line (fold increase/decrease) compared to
wild-type rice plants. Fold changes of <2 were considered relevant if
comparable shifts were shown in the transcriptome profile
Protein
10:WT
Fold
increase
7:WT Fold
increase
12:WT
Fold
increase
14:WT
Fold
increase Average
PRO7_ORYSJ 1.96 2.79 2.41 2.50 2.42
GRXC8_ORYSJ 1.42 1.08 1.57 1.54 1.40
Protein
10:WT
Fold
decrease
7:WT Fold
decrease
12:WT
Fold
decrease
14:WT
Fold
decrease Average
GLGB_ORYSJ 1.17 1.49 1.18 1.41 1.31
GLGS_ORYSJ 1.07 1.32 0.95 1.11 1.11
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biotechnology company Ventria Bioscience (Fort Collins, CO), and
lactoferrin is one of a range of rice-derived recombinant proteins
that are already marketed as technical reagents (through their
InVitria division) and some of which (including lactoferrin) are also
being developed for clinical applications. Rice and other cereal
seeds are particularly suitable for developing country applications
because they maintain the stability of recombinant proteins
accumulating in the endosperm so that a cold chain is not
necessary for product distribution, and the economy of large-
scale production makes the product affordable without detract-
ing from its safety or performance (Fischer et al., 2012; Sabalza
et al., 2013).
We expressed the HIV-neutralizing antibody 2G12 in trans-
genic rice endosperm to evaluate the potential of rice seeds as a
vehicle for inexpensive microbicide production. We also investi-
gated the biochemical and cellular processes that are influenced
by the accumulation of a heterologous recombinant protein such
as 2G12 in the endosperm to gain a better understanding of
factors that might control the accumulation of recombinant
proteins in plants. We recovered transgenic rice plants and
confirmed the presence and strong expression of the transgenes
in six independent lines, ultimately choosing two lines with the
highest antibody yields for more detailed analysis. The yields of
2G12 in rice were similar to those reported for 2G12 in other
cereal seeds and better than those reported for other antibodies,
although as stated earlier CHO cells can achieve antibody yields of
5–10 g/L albeit with more limited scalability and a lower overall
capacity. We achieved a maximum yield of 42 lg/g dry seed
weight in T3 seeds, which compares well with the 30 lg/g initially
achieved for 2G12 in maize (Rademacher et al., 2008) although
this was subsequently improved to 75 lg/g by the selective
breeding of high-performance lines and then to 100 lg/g by
subjecting the best-performing line to a dedifferentiation–regen-
eration cycle (Ramessar et al., 2008b). Our results for 2G12 were
far better than those we reported for HIV-neutralizing antibody
2F5 in maize seeds, where the maximum accumulation was
0.80 lg/mL (Sabalza et al., 2012). We are the first to report the
expression of a full-size immunoglobulin in rice, so there are no
prior studies to compare. Our data also suggest that the 2G12
yields in rice could also be improved beyond 42 lg/g dry seed
weight by selective breeding.
The localization of 2G12 in the transgenic endosperm was
investigated by immunohistochemistry and TEM, revealing that
most of the antibody accumulated in PB-II compartments and to a
lesser extent in PB-I compartments. The subcellular location of a
recombinant protein can influence its yield, structure and
functionality, but it is difficult to predict the localization of
recombinant proteins in the endosperm of cereal seeds because
protein trafficking appears to be influenced not only by the
species and tissue but also by intrinsic properties of the expressed
protein (Drakakaki et al., 2006). When a 2G12 antibody carrying
a C-terminal KDEL tag was expressed in maize endosperm, it
accumulated within ER-derived zein bodies, but no significant
labelling was observed in storage vacuoles or any other cell
compartment (Rademacher et al., 2008). In contrast, an untag-
ged version of 2G12 accumulated in the storage vacuoles and, to
a much lesser extent, also in zein bodies (Ramessar et al., 2008b).
The expression of recombinant fungal phytase in rice resulted in
the accumulation of phytase in both types of protein bodies (PB-I
and PB-II), but no additional labelling was observed in the
apoplast or other cell compartments (Drakakaki et al., 2006). Our
rice plants were transformed with the untagged version of 2G12,
and the results were similar to those reported in maize for the
same version of the antibody (Ramessar et al., 2008b). Immuno-
histochemistry showed that the signal for 2G12 overlapped with
that for glutelin, indicating that most of the antibody co-
accumulated with this storage protein in PB-II compartments,
also known as glutelin bodies. More detailed analysis by TEM
confirmed that most of the 2G12 was localized in PB-II compart-
ments and a smaller amount in PB-I compartments, but we also
observed novel protein bodies that were not present in untrans-
formed seeds, suggesting the compartments were formed de
novo as a consequence of antibody expression even though they
did not show significant 2G12 labelling. The novel protein bodies
were unusual in architecture, featuring prominent studs in the
membrane reflecting the presence of ribosomes. The induction of
novel protein bodies in transgenic rice cells has been reported
before (Torres et al., 1999; Yang et al., 2012). In our transgenic
lines, the antibody was able to induce novel protein bodies
without the benefit of a KDEL tag, suggesting that the protein
was abundant enough in the rough ER to induce the budding of
protein bodies even without a dedicated retention sequence.
Green fluorescent protein fused to rice prolamin has also been
shown to induce the formation of protein body-like structures in
transgenic rice endosperm, although the protein ultimately
accumulated in PB-I compartments (Saito et al., 2009).
Further information about the intracellular trafficking of
recombinant proteins can be gathered by analysing the glycan
profile if the protein contains canonical N-glycan acceptor sites.
The heavy chain of IgG antibodies carries an acceptor site at
residue N297 of the Fc domain, and the structure of the glycan
affects antibody-dependent cell-mediated cytotoxicity (ADCC)
and complement-dependent cytotoxicity (CDC), which can thus
be modulated by choosing an appropriate production platform
(Jung et al., 2011) or by deliberately controlling the glycan
structures (Forthal et al., 2010). Antibodies expressed in plants
typically comprise a mixture of glycoforms, ranging from the
absence of any glycans (aglycosylated heavy chain) to high-
mannose and complex-type glycans, and antibodies with single
oligosaccharides resulting from extensive glycan trimming (Baez
et al., 2000; De Wilde et al., 1998; Hristodorov et al., 2013;
Khoudi et al., 1999; Ma et al., 1994). The aglycosylated fraction
is usually a minor component. For example, 13.3% of 2G12 was
aglycosylated when the KDEL-tagged version was expressed in
standard maize and only 10.6% was aglycosylated in a sweetcorn
variety (Rademacher et al., 2008), whereas in the absence of a
KDEL tag, the aglycosylated fraction was 11.5% (Ramessar et al.,
2008b). Surprisingly, we found that the aglycosylated fraction of
the 2G12 heavy chain in transgenic rice endosperm represented
50% of the total, the remainder comprising vacuolar-type
complex N-glycans (19% MUXF and 14% MMXF), 13% individ-
ual N-acetylglucosamine (GlcNAc) residues confirming the pres-
ence of ENGase activity, and only 4% oligomannose glycans
(Man7) as expected for ER-resident proteins, suggesting that the
recombinant protein was directed through distinct trafficking
pathways characterized by different glycan signatures. In most
previous investigations, the predominant glycoforms were the
complex type (if the protein passed through the secretory
pathway to the apoplast or the storage vacuole) or the
oligomannose type (if the protein was retrieved to the ER lumen).
Only one previous study reported a prevalent aglycosylated
fraction and that involved the expression of an scFv-Fc antibody in
Arabidopsis seeds, where most of the antibodies carried oligo-
mannose glycans but 35–40% were aglycosylated (Van Dro-
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ogenbroeck et al., 2007). The authors proposed that the glyco-
sylation machinery may have been saturated at the high
expression levels they achieved, but we observed no change in
the steady-state mRNA levels of BiP and PDI, two proteins that are
usually up-regulated when the secretory pathway is under heavy
load. Indeed, we even noted a slight decline in the level of PDI
mRNA in some transgenic lines. These results suggest that a large
proportion of the heavy chain is cotranslationally imported into a
region of the ER that lacks glycosyltransferases and accumulates
in protein bodies without further modification. The remaining
proportion appears to follow the canonical pathway, undergoing
initial glycosylation in the ER lumen followed by either complex
modifications in the Golgi body and/or trimming back to a single
GlcNAc residue. Interestingly, Zhang et al. (2012) found that
nearly 70% of their rice-derived recombinant human a1-anti-
trypsin was aglycosylated, which they suggested might reflect the
trafficking of the protein to the vacuole through a latent PAC
pathway, thus providing a strategy for the production of
minimally glycosylated recombinant proteins in plants (Shimada
et al., 1997, 2002). This contrasts with the untagged version of
2G12 expressed in maize, which also accumulated in the storage
vacuoles but underwent a higher degree of glycosylation
(Ramessar et al., 2008b).
The glycosylation of 2G12 is not only important from a protein
trafficking and accumulation perspective but also because it can
affect the functionality of the protein once it has been purified.
We tested the antigen-binding efficiency of the crude extracts of
different rice lines expressing OS2G12 against purified OS2G12
and ZM2G12 as a control. We found that pure OS2G12 and
ZM2G12 bound to gp120 with near identical efficiency, and
because various glycosylated forms of ZM2G12, NT2G12 and
CHO2G12 have previously been shown to bind gp120 in a near
identical manner, this suggests that glycosylation has a negligible
impact on epitope recognition or binding (Forthal et al., 2010;
Rademacher et al., 2008). In contrast, we found that OS2G12 was
more potent than NT2G12 in our HIV-neutralization assays,
suggesting that the specific glycan profile of the rice-derived
antibody is advantageous for the relevant effector functions of
the protein, perhaps by affecting the efficiency of interactions
with different Fc receptors, as previously shown for different
glycoforms of 2G12 produced in tobacco (Forthal et al., 2010).
The tobacco antibody we used was untagged and was therefore
secreted to the apoplast and endowed predominantly with
complex-type plant glycans.
The IC50 of
CHO2G12 (with mammalian glycans) was lower
than that of purified OS2G12, which was in turn lower than that
of purified NT2G12. Although glycans do not appear to be
required to establish the domain-exchange structure that binds
the mannose cluster on gp210 or for any other aspect of antigen
binding (Calarese et al., 2003), there is increasing evidence that
glycans affect the effector functions of many antibodies, influ-
encing not only HIV-neutralization (Forthal et al., 2010) but also
the ability to neutralize anthrax LeTx (Mett et al., 2011).
However, other studies have shown the equivalence or near
equivalence of aglycosylated and glycosylated variants of the
same antibody produced in CHO cells (Hristodorov et al., 2013a),
maize (Baez et al., 2000) and soybean (Zeitlin et al., 1998), so it
appears that plants should be evaluated on a case-by-case basis
to determine the most suitable glycan profiles for specific
prophylactic or therapeutic applications. In the context of HIV,
syncytium inhibition assays offer indicative IC50 values, but it
should be borne in mind that the assays show high variability and
two- to threefold differences within an experiment should not be
regarded as significant. Interlaboratory variation is even higher,
particularly when different HIV strains and assay protocols are
used, so there is little value in the direct comparison of IC50 values
reported in different studies, particularly where different forms of
the antibody are also used. This explains why our IC50 data for
NT2G12 and CHO2G12 are inconsistent with those published in
previous reports (Forthal et al., 2010; Rademacher et al., 2008).
We also investigated the wider effects of high-level antibody
production by carrying out a proteomic analysis of transgenic and
wild-type endosperm tissue and analysing the transcripts corre-
sponding to the four differentially expressed proteins we identi-
fied. The two down-regulated proteins were both related to
starch biosynthesis, that is ADP-glucose pyrophosphorylase
(GLGS) and starch-branching enzyme (GLGB). GLGS controls a
rate-limiting step in starch biosynthesis involving carbon parti-
tioning between starch and sucrose in photosynthetic tissues
(Heldt et al., 1977; Preiss et al., 1991). It also regulates starch
biosynthesis in nonphotosynthetic sink organs such as seeds, and
in cereals, the major form of this enzyme is located in the
cytoplasm (Denyer et al., 1996; Sikka et al., 2001; Thorbjornsen
et al., 1996). GLGB is the only enzyme that can introduce a-1,6-
glucosidic linkages into a-glucans, and it is required for amylo-
pectin biosynthesis. Plants express two classes of this enzyme (BEI
and BEII) with different functions (Nakamura et al., 2003). Rice
and maize have two isoforms of the BEII enzyme (BEIIa and BEIIb),
the latter expressed only in the endosperm (Abe et al., 2014). The
down-regulation of GLGS and GLGB in the transgenic plants was
confirmed at both the mRNA and protein levels, suggesting that
the accumulation of 2G12 has a significant impact on starch
metabolism and results in the accumulation of less starch in the
seeds. Accordingly, we found that weight of the transgenic seeds
was ~22% lower than the wild-type seeds, potentially indicating
that the expression of recombinant proteins in the rice endo-
sperm can disrupt the balance between protein and carbohydrate
storage. Seed viability and germination were not affected.
This hypothesis was supported by the greater abundance of
PRO7, a seed storage protein and GRXC8 (glutaredoxin-C8), an
enzyme that scavenges reactive oxygen species (Lin et al., 2014).
In rice, prolamins accumulate in the PB-I compartments which
bud directly from the ER. The greater abundance of prolamin in
the transgenic endosperm may be related to the down-regulation
of carbohydrate metabolism discussed above and/or may reflect
the disruption of protein trafficking in the cell due to the
accumulation of 2G12 in the ER, resulting in a compensatory
mechanism as the cell attempts to sort several abundant proteins
into different compartments. The concentration of 2G12 in PB-II
compartments and the genesis of novel ER-derived protein bodies
may generate feedback at the level of storage protein deposition
that results in the up-regulation of particular prolamin genes. The
surge of proteins through the endomembrane system is likely to
cause local stress that induces the production of reactive oxygen
species, resulting in the production of glutaredoxin-C8 as a stress
response. These data suggest that yields of proteins could be
improved in rice seeds by regulating protein/carbohydrate
metabolism and protecting the endosperm from abiotic stress.
Experimental procedures
Cloning and construct design
All constructs were based on the binary vector pTRA, a derivative
of pPAM (GenBank Accession Number AY027531). The vector
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contains two tobacco RB7 scaffold attachment regions that flank
the expression cassette. The coding regions of the 2G12 heavy and
light chains (obtained from Polymun, Vienna, Austria) included
N-terminal signal sequences targeting the secretory pathway. The
expression cassette comprised the endosperm-specific rice glut-
elin-1 promoter, the maize ubiquitin-1 first intron, the Tobacco
etch virus 50 leader that acts as a translational enhancer, the
coding region and the Cauliflower mosaic virus 35S terminator,
resulting in final constructs pTRAgtiGH and pTRAgtiGL. A separate
vector was used to provide the hpt selectable marker (Christou
and Ford, 1995).
Transformation and regeneration of transgenic rice
plants
Seven-day-old mature rice zygotic embryos (Oryza sativa cv.
Nipponbarre) were transferred to osmotic medium (4.4 g/L MS
powder supplemented with 0.3 g/L casein hydrolysate, 0.5 g/L
proline, 72.8 g/L mannitol and 30 g/L sucrose) 4 h before
bombardment with 10 mg gold particles coated with the
2G12 heavy and light chain constructs and the selectable marker
hpt at a 3 : 3 : 1 ratio (Sudhakar et al., 1998; Valdez et al.,
1998). The embryos were returned to osmotic medium for 12 h
before selection on MS medium (4.4 g/L MS powder, 0.3 g/L
casein, 0.5 g/L proline and 30 g/L sucrose) supplemented with
50 mg/L hygromycin and 2.5 mg/L 2,4-dichlorophenoxyacetic
acid (2,4-D) in the dark for 2–3 weeks. Transgenic plantlets were
regenerated and hardened off in soil. Plants were grown in the
greenhouse and growth chamber at 28/20 °C day/night temper-
ature with a 10-h photoperiod and 60–90% relative humidity for
the first 50 days, followed by maintenance at 21/18 °C day/night
temperature with a 16-h photoperiod thereafter.
Characterization of rice plants and transgene expression
Genomic DNA was isolated from rice leaves by phenol extraction
(Edwards et al., 1991) and 50 ng aliquots were used for PCR
with three primers designed to generate overlapping products to
confirm transgene integrity. GoTaq DNA polymerase was used
with the program recommended by the manufacturer (Promega,
Fitchburg, Wisconsin). The positive lines were then screened for
transgene expression by dot blot. The total soluble protein (TSP)
was extracted in three volumes (v/w) of phosphate-buffered
saline (PBS). The samples were centrifuged twice (15 min, 4 °C,
13 000 g), and 4 lL of supernatant was spotted onto a
nitrocellulose membrane (Amersham; GE Healthcare, Bucking-
hamshire, UK). The membrane was blocked for 1 h with 5%
blocking buffer and probed overnight, shaking at room
temperature with alkaline phosphatase-labelled antibodies
against the heavy and light chains (Sigma-Aldrich, St. Louis,
Missouri): goat anti-human IgG Fc chain (Sigma A9544) and
goat anti-human kappa light chain (Sigma A3813), each diluted
1 : 1000 from stock. The blots were washed three times with
PBS supplemented with 0.2% Tween-20 (PBST), and the
antibody was detected using Sigma FASTTM BCIP/NBT in distilled
water.
Confirmation of antibody assembly and accumulation
(ELISA)
Three seeds representing each event were analysed by ELISA to
quantify 2G12 expression, using goat anti-human kappa light
chain (Sigma K3502) or goat anti-human IgG Fc chain (Sigma
K2136) as capture antibodies. These were diluted 1 : 200 and
coated directly onto 96-well Nunc-Immuno Maxisorp surface
plates (Nalge Nunc, Penfield, NY) and incubated overnight at
4 °C. The plates were blocked with 5% nonfat milk for 2 h and
then washed with PBST. Serial dilutions of the samples were
added to the wells and incubated for 2–3 h at room temperature.
After washing, a horseradish peroxidase (HRP)-conjugated sheep
anti-human kappa chain antiserum (The Binding Site, Birming-
ham, UK) was added to the plates at a 1 : 1000 dilution and
incubated at room temperature for 2 h before the signal was
detected with 3,30,5,50-tetramethylbenzidine (TMB) substrate
(Sigma). After 4–5 min, the signal was quantified by measuring
the absorbance at 450 nm.
Fluorescence microscopy
Sections of immature rice endosperm (20 days after pollination)
were mounted on glass slides and pre-incubated in 5% (w/v)
bovine serum albumin (BSA Fraction V) in phosphate buffer
(0.1 M, pH 7.4) and then incubated with polyclonal rabbit anti-HC
or anti-LC antiserum diluted 1 : 100. Sections were then treated
with the secondary antibody diluted in phosphate buffer (0.1 M,
pH 7.4). An AlexaFluor 594-conjugated goat anti-rabbit IgG (red
fluorophore) was used to detect 2G12, and an antiglutelin
antibody (green fluorophore) was used to detect endogenous
glutelins.
Transmission electron microscopy
Developing rice seeds (20 days after pollination) were fixed and
processed as described by Arcalis et al. (2004). Immature seeds
from wild-type and transgenic rice plants were cut into small
pieces with a razor blade under PBS (pH 7.4) and fixed in 4% (w/
v) paraformaldehyde with 0.5% (v/v) glutaraldehyde in PBS
overnight at 4 °C. After several washes in PBS, the samples were
dehydrated through an ethanol series (50%, 70%, 90%, 100%)
at 4 °C and progressively embedded in LR White resin (25% in
ethanol, 50%, 75% and pure resin for 3 h each) followed by an
additional step with fresh 100% resin. Blocks were mounted in
Beem capsules and polymerized overnight at 60 °C. Sections
showing silver interference colours were collected on gold grids,
pre-incubated in 5% (w/v) BSA in PBS for 15 min at room
temperature and then incubated with either polyclonal goat anti-
HC or anti-LC (1 : 100 in PBS) for 2 h at room temperature. After
three washes for 10 min in PBST, sections were incubated with
the secondary antibody (donkey anti-goat IgG coupled to 15-nm
colloidal gold) diluted 1 : 30 in PBS and incubated for 1 h at
room temperature. After two washes for 10 min in PBS and two
in distilled water, samples were air-dried and the sections were
observed using a FEI Tecnai G2 transmission electron microscope.
Protein A affinity chromatography
Rice seeds were ground to a fine powder, and 5 g of seed
powder was extracted overnight at 4 °C in five volumes of buffer
(19 PBS, 5 mM EDTA, 1 mM 2-mercaptoethanol, pH 7.4).
Insoluble material was removed by centrifuging twice at 8000 g
for 30 min at 4 °C. The supernatant was filtered and the
antibody concentration in the crude extract determined by ELISA.
The sample was loaded onto a protein A affinity column (ceramic
HyperDF) at a flow rate of 2 mL/min. The column was washed
with PBST and PBS, and the antibody was eluted in 100 mM
glycine (pH 3.6) containing 100 mM fructose and buffered with
0.1 volumes of 1 M sodium acetate (pH 4.75). Antibody-contain-
ing fractions were identified by the droplet Bradford method
(Bradford, 1976), and 2G12 concentrations were determined by
ELISA. Fractions containing >50 lg/mL were pooled and dialysed
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for 2 days against 10 mM sodium acetate (pH 4.75) containing
1 mM EDTA and 0.1 mM 2-mercaptoethanol (omitted in the final
dialysis step). The dialysed antibody was concentrated by ultra-
filtration using spin columns with a 30-kDa molecular weight cut-
off (MWCO). Protein extracts were separated by SDS-PAGE (12%
polyacrylamide) using precast Bis–Tris Nu-PAGE gels (Invitrogen,
Carlsbad, CA).
Glycan analysis
The antibody heavy chain band from the Coomassie-stained SDS-
PAGE gel was destained, carbamidomethylated, digested with
trypsin and extracted from gel pieces as described (Shukla et al.,
2007). The peptides were separated by capillary reversed-phase
chromatography with a Q-TOF Ultima Global mass spectrometer
(Waters, Manchester, UK) for detection (Van Droogenbroeck
et al., 2007). The MS data from the tryptic peptides were
analysed as previously described (Van Droogenbroeck et al.,
2007) and compared with data sets generated by in silico tryptic
digestion of the 2G12 coding region, using the PeptideMass
program (http://web.expasy.org/peptide_mass/). Based on the
tryptic peptide data sets, tryptic glycopeptide data sets were
generated by adding glycan mass increments to the masses of the
two identified glycopeptides.
In vitro binding to gp120 (ELISA)
The specific antigen-binding activity of 2G12 was determined by
coating ELISA wells with 100 ng recombinant gp120 from HIV
strain IIIB, provided by the MRC Centralized Facility for AIDS
Reagents, Potters Bar, UK. After washing with PBST and blocking
with BSA, serial dilutions of 2G12 were added and the amount of
bound antibody was determined using a mix of HRP-conjugated
antigamma chain and HRP-conjugated antikappa chain (The
Binding Site) at a 1 : 1000 dilution, washing with PBS, developing
the signal with TMB substrate and reading the absorbance at
450 nm.
Syncytium inhibition assay for HIV neutralization
HIV-1 neutralization was assessed using a syncytium inhibition
assay. Ten twofold serial dilutions (starting concentration 100 lg/
mL) of OS2G12, CHO2G12, NT2G12 and a non-neutralizing control
were pre-incubated with HIV-1 BaL at 10 half-maximum tissue
culture infectious doses (Terman and Bertram, 1985) per mL for
1 h at 37 °C. CD4+ human AA-2 cells were added at a density of
4 9 105 cells/mL and incubated for a further 5 days. We analysed
eight replicates per antibody dilution step. The presence of one or
more syncytia per well after 5 days was scored as positive for
infection. The 50% inhibitory concentrations (IC50) were calcu-
lated using the concentrations present during the antibody–virus
pre-incubation step (Montefiori, 2005; Wei et al., 2003).
Comparative proteomic analysis
We sampled 24 T4 seeds from line 10, 36 T4 seeds from lines 7, 12
and 14, and 48 wild-type seeds, thus providing four independent
samples of transgenic seeds expressing 2G12. Approximately
100 mg of seed powder was vortexed with 500 lL buffer (20 mM
Tris–HCl, pH 8.3, 1.5 mM KCl, 10 mM DTT, 1 mM PMSF and 0.1%
(v/v) SDS) at room temperature for 10 min and centrifuged for
5 min at 10 000 g. The protein content of the supernatant was
measured using a NanoDrop (Thermo Fisher Scientific, Waltham,
Massachusetts), and 100 lg of TSP was precipitated using 1 : 4
cold acetone. After centrifugation as above, the pellet was dried at
room temperature for 10 min and dissolved in 50 lL 50 mM
NH4HCO3 to a final concentration of 2 lg/lL and then mixed with
10 lL 50 mM ammonium bicarbonate and 25 lL 0.2% (v/v)
RapiGESTTM at 80 °C for 15 min before adding 2.5 lL 100 mM
DTT and incubating at 60 °C for a further 30 min. After
centrifuging as above, samples were mixed with 2.5 lL 300 mM
iodoacetamide in the dark at room temperature for 30 min and
then with 10 lL at 37 °C overnight. RapiGEST was precipitated
with 10 lL 5% TFA for 90 min at 37 °C, and the samples were
centrifuged at 10 000 g at 6 °C for 30 min. The supernatants
were transferred to Total Recovery vials (Waters, Milford,
Massachusetts), freeze-dried and resuspended in 100 lL
200 mM ammonium formate containing 50 fmol/lL Waters
protein standards digested with rabbit phosphorylase B. The final
protein concentration was 1 lg/lL.
The tryptic peptides were fractionated using a nanoACQUI-
TYTM system (Waters). First-dimension separation was carried out
using an XBridgeTM reversed-phase column (300 lm 9 50 mm,
5 lm C18 resin) with 20 mM ammonium formate as mobile
phase A and acetonitrile as mobile phase B. Second-dimension
separation was carried out using a Symmetry precolumn
(300 lm 9 50 mm, 5 lm C18 resin) and a HSST3 reversed-
phase column (75 lm 9 150 mm, 1.8 lm C18 resin) with 0.1%
formic acid in water as mobile phase A and 0.1% formic acid in
acetonitrile as mobile phase B. The tryptic peptides were
analysed using a Synapt G2 HDMSTM mass spectrometer (Waters)
with a hybrid quadrupole/ion mobility/orthogonal acceleration
time-of-flight (oa-TOF) geometry in positive nanoelectrospray ion
mode. Exact mass retention time (EMRT) nanoLC-MSE data (Silva
et al., 2006) were collected in alternating low and elevated
energy mode at 3 eV and 12–45 eV, respectively, with a
continuum spectra acquisition time of 1.5 s and a 0.1-s interscan
delay.
MS data were processed using ProteinLynx Global Server
(PLGS) v2.5 (Waters). Proteins were identified using the ion
accounting algorithm and a search of the UniProt Oryza spp
database with MassPREP digestion standards (MPDS). Identifica-
tions and quantitative data packaging were generated using
dedicated algorithms (Li et al., 2009; Silva et al., 2006) and a
search against a species-specific UniProt database. The intensity
measurements were normalized to those representing peptides of
the digested internal standard (Murad and Rech, 2012).
Quantitative real-time PCR
RNA was isolated from rice endosperm 25 days after pollination
as described by Li and Trick (2005) with corrections and
modifications. Extraction buffer I was 100 mM Tris (pH 8.0),
150 mM LiCl, 50 mM EDTA, 1.5% SDS, 1.5% 2-mercaptoethanol,
and extraction buffer II was 4.2 M guanidine thiocyanate, 1 M
sodium acetate, (pH 4.0), 0.5% lauryl sarcosine, 25 mM sodium
citrate (pH 7.0). The samples were processed on a Bio-Rad CFX96
system using the Quantitect reverse transcription kit (Qiagen,
Hilden, Germany) in 25 lL reactions comprising 10 ng cDNA, 19
iQ SYBR Green Supermix (Bio-Rad, Hercules, California) and
0.2 lM forward and reverse primers. To calculate relative expres-
sion levels, serial dilutions (60–0.096 ng) were used to produce
standard curves for each gene. PCRs were carried out in triplicate
using 96-well optical reaction plates, initially heating for 3 min at
95 °C followed by 40 cycles of 95 °C for 15 s, 50 °C for GLGB,
50.7 °C for GRXC8 and PRO7 and 58.3 °C for GLGS for 1 min,
and 72 °C for 20 s. Amplification specificity was confirmed by
melt curve analysis on the final PCR products in the temperature
range 50–90 °C with fluorescence acquired after each 0.5 °C
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increment. The fluorescence threshold value and gene expression
data were calculated using CFX96 system software. Values
represent the mean of three replicates  SD. The forward and
reverse primers for each gene are shown in Table S1.
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